Form 4: Collegium Pharmaceutical EVP Colleen Tupper Reports Stock Sales

Colleen Tupper, EVP & CFO of Collegium Pharmaceutical, reports selling shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 6, 2025, Colleen Tupper sold 1,949 shares of Collegium Pharmaceutical common stock at $30 per share.
• On March 7, 2025, Ms. Tupper sold 1,504 shares at a weighted average price of $30.0007, with prices ranging from $30.00 to $30.01.
• These sales were executed under a Rule 10b5-1 trading plan adopted on August 14, 2024.
• Following these transactions, Ms. Tupper directly owns 175,691 shares of Collegium Pharmaceutical common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports stock sales under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment towards the company's future prospects.

Industry Context

Executive stock sales are a common occurrence and are often pre-planned using Rule 10b5-1 trading plans to avoid accusations of insider trading. The market typically analyzes these sales in the context of the executive's overall holdings and the company's performance.

Stakeholder Impact

• The stock sales could have a minor impact on shareholders if they interpret the sales negatively, potentially leading to a slight decrease in stock price.

Key Dates